Literature DB >> 11558807

Frequency doubling technology and confocal scanning ophthalmoscopic optic disc analysis in open-angle glaucoma with hemifield defects.

L L Wu1, Y Suzuki, S Kunimatsu, M Araie, A Iwase, G Tomita.   

Abstract

PURPOSE: To evaluate the potential of frequency doubling technology for detecting early glaucomatous damage. PATIENTS AND METHODS: Forty-nine eyes of 49 patients with open-angle glaucoma with visual field defects only in one hemifield according to the Humphrey Field Analyzer 30-2 program were included. Forty-five healthy patients were also included as control subjects. In each patient, frequency doubling technology with the threshold N-30 program and optic disc analysis using the Heidelberg Retina Tomograph was performed. Frequency doubling technology test results and the Humphrey Field Analyzer test results were compared. Optic disc parameters corresponding to the hemifield designated intact by the Humphrey Field Analyzer were compared between the eyes in which the hemifield was normal by frequency doubling technology and those in which the hemifield was abnormal.
RESULTS: Forty-one percent of the 49 hemifields designated intact by the Humphrey Field Analyzer were abnormal based on frequency doubling technology, whereas 98% of the 49 hemifields designated defective by the Humphrey Field Analyzer were abnormal and 12% of the 90 hemifields designated intact by the Humphrey Field Analyzer were abnormal in healthy patients. The percentage of the hemifields designated abnormal by frequency doubling technology was significantly higher than that in healthy patients (P < 0.001). The rim volume was significantly smaller in eyes with abnormal results based on frequency doubling technology than in eyes with normal results (P < 0.05, paired t test, with Bonferroni correction for multiple comparison).
CONCLUSION: Frequency doubling technology can detect glaucomatous damage earlier than conventional static perimetry can.

Entities:  

Mesh:

Year:  2001        PMID: 11558807     DOI: 10.1097/00061198-200108000-00002

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  7 in total

1.  Continuous-wavelet-transform analysis of the multifocal ERG waveform in glaucoma diagnosis.

Authors:  J M Miguel-Jiménez; R Blanco; L De-Santiago; A Fernández; J M Rodríguez-Ascariz; R Barea; J L Martín-Sánchez; C Amo; E Sánchez-Morla; L Boquete
Journal:  Med Biol Eng Comput       Date:  2015-04-08       Impact factor: 2.602

2.  Predicting progression of glaucoma from rates of frequency doubling technology perimetry change.

Authors:  Daniel Meira-Freitas; Andrew J Tatham; Renato Lisboa; Tung-Mei Kuang; Linda M Zangwill; Robert N Weinreb; Christopher A Girkin; Jeffrey M Liebmann; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

3.  Prediction of future scotoma on conventional automated static perimetry using frequency doubling technology perimetry.

Authors:  S Kogure; Y Toda; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

Review 4.  Diagnostic tools for glaucoma detection and management.

Authors:  Pooja Sharma; Pamela A Sample; Linda M Zangwill; Joel S Schuman
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

5.  Multifocal ERG wavelet packet decomposition applied to glaucoma diagnosis.

Authors:  Juan M Miguel-Jiménez; Sergio Ortega; Luciano Boquete; José M Rodríguez-Ascariz; Román Blanco
Journal:  Biomed Eng Online       Date:  2011-05-17       Impact factor: 2.819

6.  Chromatic-achromatic perimetry in four clinic cases: Glaucoma and diabetes.

Authors:  Inmaculada Cabezos; Maria Jos Luque; Dolores de Fez; Vicenta Moncho; Vicente Camps
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

7.  The role of hemifield sector analysis in multifocal visual evoked potential objective perimetry in the early detection of glaucomatous visual field defects.

Authors:  Mohammad F Mousa; Robert P Cubbidge; Fatima Al-Mansouri; Abdulbari Bener
Journal:  Clin Ophthalmol       Date:  2013-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.